計量生物学
Online ISSN : 2185-6494
Print ISSN : 0918-4430
特集
p値は臨床研究データ解析結果報告に有用な優れたモノサシである
柳川 堯
著者情報
ジャーナル フリー

2018 年 38 巻 2 号 p. 153-161

詳細
抄録

Many clinical studies are conducted in Japan with sample sizes that are not deter-mined statistically. Application of Neyman-Pearson type statistical tests to data from such studies is not justifiable and should be stopped. Also 5% significance level that is commonly employed in a clinical study without taking into account disease, drug and other factors is not justifiable. Alternatively, the use of p-value is recommended in this paper as a measure of showing the magnitude of difference of two treatments; it is the role of principal investigator to summarize the study results by considering disease, drug and other factors, sample sizes and p-value.

著者関連情報
© 2018 日本計量生物学会
前の記事 次の記事
feedback
Top